Free Trial

Amdocs (NASDAQ:DOX) Director John Anthony Macdonald Purchases 1,000 Shares of Company Stock

Amdocs logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Director John Anthony Macdonald bought 1,000 Amdocs shares at an average of $41.63, increasing his stake by 4.13% to 25,189 shares.
  • Amdocs reported quarterly earnings and revenue in line with analyst expectations, with revenue up 3.8% year over year. It also declared a quarterly dividend of $0.569 per share, equivalent to an annualized yield of about 5.2%.
  • Analyst sentiment is mixed, with MarketBeat’s consensus rating at “Hold”; reports also cite concerns about the company’s fiscal 2027 outlook and investigations into potential securities claims.
  • MarketBeat previews top five stocks to own in December.

Amdocs Limited (NASDAQ:DOX - Get Free Report) Director John Anthony Macdonald acquired 1,000 shares of the business's stock in a transaction dated Tuesday, November 10th. The stock was acquired at an average price of $41.63 per share, for a total transaction of $41,630.00. Following the completion of the transaction, the director owned 25,189 shares in the company, valued at approximately $1,048,618.07. The trade was a 4.13% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Amdocs Trading Up 2.4%

Shares of DOX traded up $1.05 during mid-day trading on Thursday, hitting $44.17. 327,803 shares of the company's stock traded hands, compared to its average volume of 1,311,953. The company has a quick ratio of 0.94, a current ratio of 0.94 and a debt-to-equity ratio of 0.23. Amdocs Limited has a 1 year low of $39.96 and a 1 year high of $84.95. The firm has a market capitalization of $4.77 billion, a P/E ratio of 9.44, a PEG ratio of 1.35 and a beta of 0.42. The business's 50-day moving average price is $58.25 and its 200-day moving average price is $61.37.

Amdocs (NASDAQ:DOX - Get Free Report) last announced its earnings results on Tuesday, November 3rd. The technology company reported $1.98 EPS for the quarter, meeting analysts' consensus estimates of $1.98. Amdocs had a return on equity of 20.81% and a net margin of 10.59%. The company had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.19 billion. During the same quarter in the prior year, the company earned $1.83 earnings per share. The firm's revenue for the quarter was up 3.8% on a year-over-year basis. As a group, sell-side analysts forecast that Amdocs Limited will post 5.82 EPS for the current fiscal year.

Amdocs Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 29th. Shareholders of record on Thursday, December 31st will be issued a $0.5690 dividend. The ex-dividend date is Thursday, December 31st. This represents a $2.28 annualized dividend and a yield of 5.2%. Amdocs's dividend payout ratio is 48.61%.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on DOX shares. Weiss Ratings raised shares of Amdocs from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Friday, October 23rd. Oppenheimer downgraded shares of Amdocs from an "outperform" rating to a "market perform" rating in a research note on Wednesday, November 4th. Zacks Research lowered shares of Amdocs from a "hold" rating to a "strong sell" rating in a report on Monday. Stifel Nicolaus cut their price objective on Amdocs from $71.00 to $46.00 and set a "buy" rating on the stock in a research report on Wednesday, November 4th. Finally, Wall Street Zen cut Amdocs from a "buy" rating to a "hold" rating in a research report on Saturday, November 7th. Two analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $69.00.

Check Out Our Latest Stock Report on Amdocs

Latest Amdocs News

Here's some of the latest news about DOX:

  • Negative Sentiment: Multiple law firms have announced investigations into potential securities claims, citing allegations that Amdocs may have issued materially misleading business information. These are investigations, not findings of wrongdoing, but they could add reputational and legal uncertainty. Pomerantz investigation notice Rosen investigation notice
  • Negative Sentiment: The central concern remains Amdocs’ fiscal 2027 outlook, reportedly weakened by an escalating T-Mobile dispute. The resulting disappointment was associated with a roughly 30% one-session share decline on November 4, despite quarterly results being in line with expectations. Levi & Korsinsky notice
  • Negative Sentiment: Zacks Research downgraded Amdocs from “hold” to “strong sell,” adding to the cautious analyst sentiment. Zacks Research ratings

Hedge Funds Weigh In On Amdocs

Several institutional investors and hedge funds have recently added to or reduced their stakes in DOX. Advisors Asset Management Inc. bought a new position in shares of Amdocs in the 3rd quarter worth about $40,432,000. Composition Wealth LLC purchased a new position in Amdocs during the 3rd quarter valued at about $309,000. Voya Investment Management LLC boosted its stake in Amdocs by 155.6% during the third quarter. Voya Investment Management LLC now owns 28,213 shares of the technology company's stock worth $1,613,000 after acquiring an additional 17,173 shares in the last quarter. Public Sector Pension Investment Board bought a new stake in Amdocs during the third quarter worth about $3,281,000. Finally, Global Retirement Partners LLC boosted its stake in Amdocs by 16.8% during the third quarter. Global Retirement Partners LLC now owns 2,007 shares of the technology company's stock worth $115,000 after acquiring an additional 289 shares in the last quarter. Hedge funds and other institutional investors own 92.02% of the company's stock.

About Amdocs

(Get Free Report)

Amdocs provides software and services to communications and media companies. Its offerings include business and operational support systems for billing, customer management, service delivery and network operations, as well as cloud and digital solutions that help clients modernize their businesses and improve customer experiences. Founded in 1982, Amdocs serves communications and media providers in markets around the world. The company is headquartered in the St. Louis, Missouri, area and is led by President and Chief Executive Officer Shuky Sheffer.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amdocs Right Now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines